UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000014314 |
|---|---|
| Receipt number | R000016615 |
| Scientific Title | A phase II study of maintenance bevacizumab plus docetaxel following induction chemotherapy with cisplatin, pemetrexed plus bevacizumab for advanced non-squamous non-small-cell lung cancer |
| Date of disclosure of the study information | 2014/06/19 |
| Last modified on | 2020/08/25 10:41:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/06/19 16:11:58 | ||
| 2 | Update | 2014/06/19 16:12:56 | Acronym |
|
| 3 | Update | 2014/06/19 16:57:17 | Email |
|
| 4 | Update | 2014/06/19 19:34:14 | Key inclusion criteria Key exclusion criteria |
|
| 5 | Update | 2016/06/22 15:55:05 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2016/12/22 14:44:39 | Key inclusion criteria |
|
| 7 | Update | 2017/06/21 09:07:21 | Recruitment status |
|
| 8 | Update | 2020/08/25 10:27:42 | UMIN ID1 |
|
| 9 | Update | 2020/08/25 10:33:04 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 10 | Update | 2020/08/25 10:33:48 | Date of IRB Last follow-up date |
|
| 11 | Update | 2020/08/25 10:39:13 | Recruitment status |
|
| 12 | Update | 2020/08/25 10:41:39 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
